The metabolic syndrome vis-à-vis syndrome of insulin resistance: The perfect squall

Coronary Artery Disease

Volumn 16, Issue 8, 2005, Pages 461-463

  Sobel, Burton E ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

Coronary disease; Diabetes; Impaired glucose tolerance

Indexed keywords

CARDIOVASCULAR RISK; CLINICAL FEATURE; CORONARY ARTERY DISEASE; HUMAN; INSULIN RESISTANCE; MEDICAL PRACTICE; METABOLIC SYNDROME X; PRIORITY JOURNAL; SHORT SURVEY;

EID: 33748579529     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200512000-00001     Document Type: Short Survey

References (10)

1. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005; 9:2289-2304.
2. Sobel BE, Furgerg CD. Surrogates, semantics, and sensible public policy. Special commentary. Circulation 1997; 95:1661-1663.
3. Ambowitz LL, Sobel BE. Cardiovascular consequences of PCOS. In: Andrea Dunaif, editor. Endocrinology and metabolism clinical of North America. Philadelphia: WB Saunders Company; 1999. pp. 439-458.
4. Dunaif AE. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997; 18:774-800.
5. Lowell BB, Shulman GI. Mitochondrial dysfunction and type 2 diabetes. Science 2005; 307:384-387.
6. Boden G. Interaction between free fatty acids and glucose metabolism. Curr Opin Clin Nutr Metab Care 2002; 5:545-549.
7. Dormandy JA, Charbonnel B, Eckland DJ, Erdmann E, Massi-Benedetti M, Moules IK, et al., PROactive investigators. Secondary prevention of microvascular events in pateints with type 2 diabetes in the PROactive Study (PROspective pioglitazone clinical trial in macrovascular events): a randomized contrilled trial. Lancet 2005; 366:1279-1289.
8. Schneider DJ. Abnormalities of coagulation, platelet function, and fibrinolysis associated with syndromes of insulin resistance. Coron Artery Dis 2005; 16:473-476.
9. LeWinter MM. Association of syndromes of insulin resistance with coronary artery disease. Coron Artery Dis 2005; 16:477-480.
10. Van Belle E, Banters C, Mc Fadden E, Bertrand ME. Nature of coronary disease in patients with insulin resistance and its impact on revascularization strategies. Coron Artery Dis 2005; 16:481-487.